The comparison of the three assays for determination of fecal calprotectin in inflammatory bowel disease

INTRODUCTION: Fecal calprotectin is a biomarker for monitoring inflammatory bowel disease (IBD) activity. Our aim, therefore, was to evaluate two new assays, the point of care test Quantum Blue and the Liaison Calprotectin with respect to the Calprest, commonly used assay, and to determine their per...

Descripción completa

Detalles Bibliográficos
Autores principales: Osredkar, Joško, Kurent, Tina, Fabjan, Teja, Kumer, Kristina, Božnar Alič, Elizabeta, Drobne, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Society of Medical Biochemistry and Laboratory Medicine 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047788/
https://www.ncbi.nlm.nih.gov/pubmed/33927557
http://dx.doi.org/10.11613/BM.2021.020707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047788/
https://www.ncbi.nlm.nih.gov/pubmed/33927557
http://dx.doi.org/10.11613/BM.2021.020707

Ejemplares similares